Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Gille

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
The Journal of Biological Chemistry|June 25, 2002
Distinct interactions of GTP, UTP, and CTP with G(s) proteinsAndreas Gille, Hui-Yu Liu, Stephen R Sprang, et al.
Nucleic Acids Research|May 13, 2014
Alignment-Annotator web server: rendering and annotating sequence alignmentsChristoph Gille, Michael Fähling, Birgit Weyand, et al.
The Journal of Clinical Investigation|February 15, 2011
Nicotinic acid inhibits progression of atherosclerosis in mice through its receptor GPR109A expressed by immune cellsMartina Lukasova, Camille Malaval, Andreas Gille, et al.
The Journal of Biological Chemistry|December 25, 2002
GDP affinity and order state of the catalytic site are critical for function of xanthine nucleotide-selective Galphas proteinsAndreas Gille, Katharina Wenzel-Seifert, Michael B Doughty, et al.
Molecular Pharmacology|September 30, 2006
Nicotinic acid-induced flushing is mediated by activation of epidermal langerhans cellsZoltán Benyó, Andreas Gille, Clare L Bennett, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 25, 2009
Characterization of mouse heart adenylyl cyclaseMartin Göttle, Jens Geduhn, Burkhard König, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 28, 2014
CSL112 enhances biomarkers of reverse cholesterol transport after single and multiple infusions in healthy subjectsAndreas Gille, Rachael Easton, Denise D'Andrea, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 14, 2018
CSL112 (Apolipoprotein A-I [Human]) Enhances Cholesterol Efflux Similarly in Healthy Individuals and Stable Atherosclerotic Disease PatientsAndreas Gille, Denise D'Andrea, Michael A Tortorici, et al.
Journal of Clinical Pharmacology|October 15, 2013
A multiple ascending dose study of CSL112, an infused formulation of ApoA-IRachael Easton, Andreas Gille, Denise D'Andrea, et al.
The Journal of Biological Chemistry|December 14, 2004
Structural basis for the inhibition of mammalian membrane adenylyl cyclase by 2 '(3')-O-(N-Methylanthraniloyl)-guanosine 5 '-triphosphateTung-Chung Mou, Andreas Gille, David A Fancy, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
The Journal of Biological Chemistry|June 25, 2002
Distinct interactions of GTP, UTP, and CTP with G(s) proteinsAndreas Gille, Hui-Yu Liu, Stephen R Sprang, et al.
Nucleic Acids Research|May 13, 2014
Alignment-Annotator web server: rendering and annotating sequence alignmentsChristoph Gille, Michael Fähling, Birgit Weyand, et al.
The Journal of Clinical Investigation|February 15, 2011
Nicotinic acid inhibits progression of atherosclerosis in mice through its receptor GPR109A expressed by immune cellsMartina Lukasova, Camille Malaval, Andreas Gille, et al.
The Journal of Biological Chemistry|December 25, 2002
GDP affinity and order state of the catalytic site are critical for function of xanthine nucleotide-selective Galphas proteinsAndreas Gille, Katharina Wenzel-Seifert, Michael B Doughty, et al.
Molecular Pharmacology|September 30, 2006
Nicotinic acid-induced flushing is mediated by activation of epidermal langerhans cellsZoltán Benyó, Andreas Gille, Clare L Bennett, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 25, 2009
Characterization of mouse heart adenylyl cyclaseMartin Göttle, Jens Geduhn, Burkhard König, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 28, 2014
CSL112 enhances biomarkers of reverse cholesterol transport after single and multiple infusions in healthy subjectsAndreas Gille, Rachael Easton, Denise D'Andrea, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 14, 2018
CSL112 (Apolipoprotein A-I [Human]) Enhances Cholesterol Efflux Similarly in Healthy Individuals and Stable Atherosclerotic Disease PatientsAndreas Gille, Denise D'Andrea, Michael A Tortorici, et al.
Journal of Clinical Pharmacology|October 15, 2013
A multiple ascending dose study of CSL112, an infused formulation of ApoA-IRachael Easton, Andreas Gille, Denise D'Andrea, et al.
The Journal of Biological Chemistry|December 14, 2004
Structural basis for the inhibition of mammalian membrane adenylyl cyclase by 2 '(3')-O-(N-Methylanthraniloyl)-guanosine 5 '-triphosphateTung-Chung Mou, Andreas Gille, David A Fancy, et al.
Pageof 5